Usman Baber

Usman Baber's AcademicInfluence.com Rankings

Usman Baber

Computer Science

#6775

World Rank

#7140

Historical Rank

Informatics

#42

World Rank

#43

Historical Rank

computer-science Degrees

Usman Baber

Philosophy

#7377

World Rank

#10583

Historical Rank

Logic

#4432

World Rank

#5722

Historical Rank

philosophy Degrees

Download Badge

Computer Science
Philosophy

Usman Baber's Degrees

Doctorate Medicine Harvard University
PhD Biomedical Informatics Harvard University

Why Is Usman Baber Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Usman Baber's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease (2017) (1358)
Incidence (1931) (868)
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. (2016) (847)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) (539)
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study (2013) (532)
Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies. (2016) (410)
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. (2016) (406)
Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. (2015) (349)
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting (2017) (338)
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. (2015) (306)
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. (2011) (278)
Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2011) (237)
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). (2013) (199)
Deep learning for cardiovascular medicine: a practical primer. (2019) (161)
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention (2018) (156)
Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. (2016) (143)
Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (137)
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials (2013) (134)
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials (2015) (128)
Machine learning prediction in cardiovascular diseases: a meta-analysis (2020) (121)
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. (2016) (109)
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. (2020) (104)
Optical coherence tomography assessment of the mechanistic effects of rotational and orbital atherectomy in severely calcified coronary lesions (2015) (103)
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. (2016) (103)
Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans (2018) (101)
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. (2012) (97)
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study (2017) (96)
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials (2021) (96)
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials. (2019) (94)
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease (2019) (90)
Digital Mammography and Screening for Coronary Artery Disease. (2016) (89)
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. (2021) (79)
Cardiovascular risk factors in patients with chronic kidney disease (2009) (77)
Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). (2011) (75)
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions (2018) (74)
Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling (2018) (70)
Ticagrelor With or Without Aspirin After Complex PCI (2020) (66)
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry. (2018) (66)
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. (2020) (65)
Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry (2015) (64)
Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer‐generation DES: Findings from a large multiethnic registry (2018) (63)
Increased Thin-Cap Neoatheroma and Periprocedural Myocardial Infarction in Drug-Eluting Stent Restenosis: Multimodality Intravascular Imaging of Drug-Eluting and Bare-Metal Stents (2013) (61)
Female gender and mortality after percutaneous coronary intervention: Results from a large registry (2012) (60)
Sex‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study (2017) (60)
Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention. (2015) (60)
Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2016) (60)
Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease (2018) (59)
Negative Risk Markers for Cardiovascular Events in the Elderly. (2019) (58)
Contrasting Cholesterol Management Guidelines for Adults with CKD. (2015) (57)
Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease. (2016) (56)
Stenting of complex lesions: an overview (2010) (54)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis. (2016) (53)
Future Direction for Using Artificial Intelligence to Predict and Manage Hypertension (2018) (53)
High-efficiency SPECT MPI: Comparison of automated quantification, visual interpretation, and coronary angiography (2013) (53)
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy. (2020) (53)
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort. (2008) (51)
Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. (2012) (51)
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE‐TAVI AF trial (2018) (51)
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study. (2017) (50)
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. (2012) (50)
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). (2018) (48)
Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers. (2013) (48)
Fibrous Cap Thickness by Optical Coherence Tomography In Vivo. (2017) (48)
Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. (2016) (47)
Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention. (2020) (47)
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention. (2019) (44)
Multimodality Intravascular Imaging to Evaluate Sex Differences in Plaque Morphology in Stable CAD. (2016) (43)
Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis: The Multi-Ethnic BioImage Study. (2015) (42)
Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis (2016) (39)
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. (2017) (39)
Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis. (2020) (39)
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2015) (38)
Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. (2009) (37)
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity (2013) (36)
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. (2021) (33)
Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. (2016) (33)
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (33)
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). (2015) (32)
Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (32)
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. (2016) (31)
The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study. (2015) (31)
Meta-Analysis of Radial Versus Femoral Access for Percutaneous Coronary Interventions in Non-ST-Segment Elevation Acute Coronary Syndrome. (2016) (30)
Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis (2018) (30)
Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials. (2017) (29)
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. (2018) (29)
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor (2017) (29)
A model for the prediction of a successful stress-first Tc-99m SPECT MPI (2012) (28)
DAPT duration after DES: what is the "mandatory" duration? (2015) (28)
Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview. (2012) (28)
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. (2021) (28)
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention (2016) (27)
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort. (2017) (27)
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) (2017) (27)
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials. (2016) (27)
Procedural and one-year outcomes of patients treated with orbital and rotational atherectomy with mechanistic insights from optical coherence tomography. (2019) (26)
Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practice. (2012) (26)
Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies (2013) (26)
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (25)
Sleep Duration and Cardiovascular Health in a Representative Community Population (from NHANES, 2005 to 2016). (2020) (25)
Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes. (2016) (25)
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study (2017) (24)
Resistant in‐stent restenosis in the drug eluting stent era (2016) (24)
Three-dimensional volumetric assessment of coronary artery calcification in patients with stable coronary artery disease by OCT. (2017) (24)
Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty. (2014) (24)
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on‐treatment platelet reactivity (2016) (24)
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study. (2017) (23)
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) (2017) (23)
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry (2021) (23)
Prognostic Significance of Elevated Baseline Troponin in Patients With Acute Coronary Syndromes and Chronic Kidney Disease Treated With Different Antithrombotic Regimens: A Substudy From the ACUITY Trial (2012) (23)
Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study. (2015) (23)
Balancing ischaemia and bleeding risks with novel oral anticoagulants (2014) (22)
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (22)
Genotype-Dependent Impairment of Hemoglobin Clearance Increases Oxidative and Inflammatory Response in Human Diabetic Atherosclerosis (2012) (22)
Safety and Efficacy of Polymer-Free Drug-Eluting Stents: Amphilimus-Eluting Cre8 Versus Biolimus-Eluting BioFreedom Stents (2019) (21)
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) (2018) (21)
Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. (2007) (21)
An Algorithm for the Use of Embolic Protection During Atherectomy for Femoral Popliteal Lesions. (2017) (21)
DNA Sequence Variation in ACVR1C Encoding the Activin Receptor-Like Kinase 7 Influences Body Fat Distribution and Protects Against Type 2 Diabetes (2018) (21)
A comparison of coronary CTA and stress testing using high-efficiency SPECT MPI for the evaluation of chest pain in the emergency department (2014) (20)
An allele-specific PCR system for rapid detection and discrimination of the CYP2C19∗4A, ∗4B, and ∗17 alleles: implications for clopidogrel response testing. (2013) (19)
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. (2018) (19)
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. (2018) (19)
The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub‐analysis of the BRAVO study (2014) (19)
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (19)
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. (2017) (18)
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis. (2021) (18)
Plaque morphology predictors of side branch occlusion after provisional stenting in coronary bifurcation lesion: Results of optical coherence tomography bifurcation study (ORBID) (2017) (18)
How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes? (2011) (18)
A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week. (2021) (18)
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry. (2019) (17)
Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry (2019) (17)
Clustering of Acute and Subacute Stent Thrombosis Related to the Introduction of Generic Clopidogrel (2014) (17)
Patients with Chronic Kidney Disease/Diabetes Mellitus: The High-Risk Profile in Acute Coronary Syndrome (2013) (17)
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. (2017) (17)
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention (2018) (16)
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. (2021) (16)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis (2016) (16)
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). (2018) (16)
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease (2017) (15)
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry). (2018) (15)
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk (2020) (15)
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. (2021) (15)
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry (2018) (15)
Outcomes of patients calling emergency medical services for suspected acute cardiovascular disease. (2015) (15)
Anemia and Acute Coronary Syndrome: Time for Intervention Studies (2016) (15)
Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study. (2014) (15)
Abstract 13371: Frequency and Clinical Impact of Nuisance Bleeding Among Patients Receiving Aspirin and Clopidogrel: Insights from the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (2011) (15)
Outcomes of Impella‐supported high‐risk nonemergent percutaneous coronary intervention in a large single‐center registry (2020) (14)
Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents (2015) (14)
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention (2020) (14)
Clinical features and prognosis of patients with spontaneous coronary artery dissection. (2020) (13)
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA‐PRATIC Study (2020) (13)
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry (2016) (13)
Efficacy and safety of routine thrombus aspiration in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An updated systematic review and meta‐analysis of randomized controlled trials (2016) (13)
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention: Insights From the PARIS Registry (2019) (12)
Anticoagulation for Mechanical Heart Valves in Patients with and without Atrial Fibrillation (2010) (12)
Incremental prognostic value of coronary computed tomographic angiography high-risk plaque characteristics in newly symptomatic patients. (2016) (12)
Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. (2017) (12)
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry (2018) (12)
Frequency of 30‐day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock (2019) (12)
Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort (2020) (11)
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease (2018) (11)
Plaque Morphology Predictors of Side Branch Occlusion After Main Vessel Stenting in Coronary Bifurcation Lesions: Optical Coherence Tomography Imaging Study. (2016) (11)
Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents. (2010) (11)
Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols. (2018) (11)
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. (2019) (11)
Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudin. (2014) (11)
Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis. (2016) (11)
Impact of insulin treated and non‐insulin‐treated diabetes compared to patients without diabetes on 1‐year outcomes following contemporary PCI (2020) (11)
P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention (2022) (11)
Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: Competing factors influence mortality, myocardial infarction, and target lesion revascularization (2013) (11)
Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention. (2017) (10)
Predictors of side branch compromise in calcified bifurcation lesions treated with orbital atherectomy (2018) (10)
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis (2018) (10)
The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry (2020) (10)
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry). (2017) (10)
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. (2017) (10)
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention. (2019) (10)
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis. (2021) (10)
Bioimaging and Subclinical Cardiovascular Disease in Low- and Middle-Income Countries (2014) (10)
Coronary artery disease in the young in the US population-based cohort. (2020) (9)
Impact of renal function on the immediate and long-term outcomes of percutaneous recanalization of coronary chronic total occlusions: A systematic review and meta-analysis. (2020) (9)
Coronary artery revascularization in chronic kidney disease: time for a randomized trial. (2015) (9)
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial (2017) (9)
One‐year results of the ICON (ionic versus non‐ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study (2016) (9)
Defining PCI complexity in the contemporary DES era: Clarity or confusion? (2018) (9)
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention (2019) (9)
Is There Attenuation of Benefit of Invasive Therapy in Patients with Chronic Kidney Disease? Results from Randomized Trials and Registry Data (2012) (9)
Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes. (2015) (9)
A null mutation in ANGPTL8 does not associate with either plasma glucose or type 2 diabetes in humans (2016) (9)
Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial. (2019) (9)
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction (2021) (9)
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents. (2020) (9)
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes (2017) (9)
Aortic stenosis: role of balloon aortic valvuloplasty. (2013) (9)
Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry (2016) (9)
Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin (2014) (8)
A sex paradox in clinical outcomes following complex percutaneous coronary intervention. (2020) (8)
Temporal trends, determinants, and impact of high‐intensity statin prescriptions after percutaneous coronary intervention: Results from a large single‐center prospective registry (2019) (8)
Hemoglobin A1c and Cardiovascular Outcomes Following Percutaneous Coronary Intervention: Insights From a Large Single-Center Registry. (2021) (8)
Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin) ± Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention. (2018) (8)
DOES AGGRESSIVE STATIN THERAPY REDUCE CORONARY ATHEROSCLEROTIC PLAQUE LIPID CONTENT? RESULTS FROM: REDUCTION IN YELLOW PLAQUE BY AGGRESSIVE LIPID LOWERING THERAPY (YELLOW) TRIAL (2012) (8)
Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial. (2019) (8)
Association between age and readmission after percutaneous coronary intervention for acute myocardial infarction (2020) (8)
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI. (2021) (8)
Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry. (2019) (7)
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. (2019) (7)
Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial. (2019) (7)
Mid‐term outcomes of consecutive 998 cases of coronary atherectomy in contemporary clinical practice (2017) (7)
DETECTION AND IMPACT OF SUBCLINICAL CORONARY AND CAROTID ATHEROSCLEROSIS ON CARDIOVASCULAR RISK PREDICTION AND RECLASSIFICATION IN ASYMPTOMATIC US ADULTS: INSIGHTS FROM THE HIGH RISK PLAQUE BIOIMAGE STUDY (2014) (7)
Impact of stent diameter on outcomes following percutaneous coronary intervention with second‐generation drug‐eluting stents: Results from a large single‐center registry (2019) (7)
Balancing ischaemia and bleeding risks with novel oral anticoagulants (2014) (7)
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry (2020) (7)
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. (2019) (7)
Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysis. (2009) (6)
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS (2019) (6)
Procedural and 1‐year clinical outcomes of orbital atherectomy for treatment of coronary in‐stent restenosis: A single‐center, retrospective study (2020) (6)
Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration. (2019) (6)
Impact of high on‐treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT‐DES substudy (2019) (6)
OPTIMAL P2Y12 INHIBITOR IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS (2016) (6)
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. (2023) (6)
Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysis. (2018) (6)
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes. (2016) (6)
Bayes Factor Meta-Analysis of the Mortality Claim for Peripheral Paclitaxel-Eluting Devices. (2019) (6)
Predictors of In-Hospital Mortality after Transcatheter Aortic Valve Implantation. (2019) (6)
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2019) (6)
Variability in low-density lipoprotein cholesterol and cardiovascular risk: should consistency be a new target? (2015) (6)
Relation of Internal Elastic Lamellar Layer Disruption to Neointimal Cellular Proliferation and Type III Collagen Deposition in Human Peripheral Artery Restenosis. (2016) (6)
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry (2020) (5)
Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery disease (2020) (5)
Improving fitness to achieve health: shifting the focus from theory to practice. (2015) (5)
Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study. (2021) (5)
Trends and Outcomes of Intravascular Imaging-guided Percutaneous Coronary Intervention in the United States (2019) (5)
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI (2021) (5)
Safety and efficacy of the bioabsorbable polymer everolimus‐eluting stent versus durable polymer drug‐eluting stents in high‐risk patients undergoing PCI: TWILIGHT‐SYNERGY (2020) (5)
Sunday, 26 August 2012 (2012) (5)
Increased Lipid Length, Macrophage Infiltration, and Neovascularization in Coronary Atheroma From Patients With Chronic Kidney Disease. (2017) (5)
Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry. (2015) (5)
The Shifting Pendulum for DAPT After PCI: Balancing Long-Term Risks for Bleeding and Thrombosis. (2015) (5)
One‐year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug‐eluting stents (2020) (4)
Clinical and angiographic predictors of haemodynamically significant angiographic lesions: development and validation of a risk score to predict positive fractional flow reserve. (2017) (4)
Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI. (2020) (4)
Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study. (2014) (4)
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI (2022) (4)
Current developments in dual antiplatelet therapy after stenting. (2014) (4)
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study (2020) (4)
Acute cholecystitis and myocardial infarction: a case study with coronary involvement (2016) (4)
Assessment of Fibrous Cap Thickness by Optical Coherence Tomography In Vivo: Reproducibility and Standardization (2016) (4)
IMPACT OF GENDER ON PATTERNS OF DUAL ANTIPLATELET THERAPY CESSATION AND NON-ADHERENCE: ONE-YEAR RESULTS FROM THE PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS (PARIS), AN OBSERVATIONAL SINGLE-ARM STUDY (2013) (4)
Antiplatelet treatments: recent evidence from randomized controlled trials (2017) (4)
Percutaneous Coronary Intervention Outcomes in Very Elderly Patients From a Single Large-Volume Tertiary Care Center, Specifically Focusing on Nonagenarians. (2017) (4)
Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single‐center registry study (2020) (4)
Self-employment and cardiovascular risk in the US general population (2020) (4)
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry (2019) (3)
Outcomes by Gender and Ethnicity After Percutaneous Coronary Intervention. (2019) (3)
Ticagrelor Monotherapy After Coronary Stenting: Is the GLASS Half Full or Half Empty? (2019) (3)
Medication Nonadherence: A Challenging Conundrum for Clinical Trials, Patients, and Clinicians. (2022) (3)
Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition study (2016) (3)
IMPACT OF EJECTION FRACTION ON MORTALITY IN PATIENTS UNDERGOING PCI: A PATIENT-LEVEL POOLED ANALYSIS FROM THE REPLACE-2, ACUITY AND HORIZONS-AMI TRIALS (2012) (3)
Predicting risk for bleeding after PCI: Another step in the right direction but work remains. (2018) (3)
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry (2021) (3)
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial (2017) (3)
Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy (2022) (3)
Monday, 27 August 2012 (2012) (3)
1-Year outcomes with COMBO stents in small vessel coronary disease: Subgroup analysis from the COMBO collaboration. (2020) (3)
Comparison of Transaortic and Subclavian Approaches for Transcatheter Aortic Valve Replacement in Patients with No Transfemoral Access Options (2018) (3)
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI (2021) (3)
Sex differences in 1‐year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration (2020) (3)
Optimal Antiplatelet Therapy in ST-Segment Elevation Myocardial Infarction. (2016) (3)
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry). (2020) (3)
The Prematurely Stopped Clinical Trial: An Unfinished Symphony. (2017) (3)
Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease (2021) (3)
Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry. (2020) (3)
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry (2019) (3)
Correlates and Impact of Coronary Artery Calci ﬁ cations in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (3)
Effect of Chronic Kidney Disease in WomenUndergoing Percutaneous CoronaryIntervention With Drug-ElutingStents (2)
Anticoagulation Strategies in Non-Critically Ill Patients Hospitalized with COVID-19: A Randomized Clinical Trial (2023) (2)
DIGITAL MAMMOGRAPHY: SCREENING FOR CORONARY ARTERY DISEASE? (2016) (2)
Abstract 15919: Impact of Bivalirudin Therapy on Mortality in Patients With High Risk Features Undergoing PCI: A Patient-Level Pooled Analysis From the REPLACE-2, ACUITY and HORIZONS-AMI Trials (2011) (2)
Clinical trials in long-term antiplatelet therapies: focus on the role of aspirin. (2019) (2)
Antiplatelet therapy after drug-eluting stent implantation. (2015) (2)
COMPARISON OF BLEEDING DEFINITIONS, BARC, GUSTO, TIMI AND VARC IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A TWO-CENTER REGISTRY (2012) (2)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization (2016) (2)
WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY (2017) (2)
Relationship between hemoglobin A1C and characteristics of plaque vulnerability in stable coronary disease: an optical coherence tomography study (2022) (2)
TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation. (2016) (2)
2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations (2021) (2)
Exercise physiology in the catheterization laboratory: still alive and well! (2012) (2)
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration (2021) (2)
Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndrome receiving Ticagrelor - The COMET (Comparison Morphine, Fentayl and Ticagrelor) randomized controlled trial (2)
TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes. (2016) (2)
Duration of Dual Antiplatelet Therapy After PCI: How Short Can We Go? (2020) (2)
ASSOCIATION OF STENT THROMBOSIS AND PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS: SIX MONTH RESULTS OF THE PARIS REGISTRY (2012) (2)
Mobile application to optimize care for ST-segment elevation myocardial infarction patients in a large healthcare system, STEMIcathAID: rationale and design (2021) (2)
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry). (2022) (2)
PHYSIOLOGIC IMPACT OF CHRONIC KIDNEY DISEASE ON WHOLE BLOOD CLOT KINETICS AND STRENGTH (2012) (2)
Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions. (2018) (2)
MULTIMODALITY INTRAVASCULAR IMAGING TO PREDICT PERIPROCEDURAL MYOCARDIAL INFARCTION DURING PERCUTANEOUS CORONARY INTERVENTION (2015) (2)
Use of prasugrel and clinical outcomes in African‐American patients treated with percutaneous coronary intervention for acute coronary syndromes (2019) (2)
Seizure-related takotsubo cardiomyopathy in a patient with recurrent malignant meningioma (2014) (2)
Acute kidney injury: Prevention of contrast-induced AKI—the ongoing saga (2012) (2)
The Challenge of Diabetes Mellitus in the Contemporary Percutaneous Coronary Intervention Era: Are We Making Progress? (2018) (2)
Comparison of provisional 1-stent and 2-stent strategies in diabetic patients with true bifurcation lesions: the EES bifurcation study. (2014) (2)
Ventricular Fibrillation Associated With Coronary Plaque Erosion Detected by Optical Coherence Tomography. (2019) (2)
PREDICTORS OF 1 YEAR NET ADVERSE CARDIOVASCULAR EVENTS (NACE) AMONG ACS PATIENTS UNDERGOING PCI WITH CLOPIDOGREL OR PRASUGREL: ANALYSIS FROM THE PROMETHEUS REGISTRY (2016) (2)
PREDICTORS OF MAJOR BLEEDING POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY (2012) (1)
Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome? (2014) (1)
HIGH BLEEDING RISK AFTER PERCUTANEOUS CORONARY INTERVENTION: IMPACT OF RACE/ETHNICITY (2020) (1)
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index. (2022) (1)
PROCEDURAL AND ONE-YEAR OUTCOMES IN PATIENTS TREATED WITH ROTATIONAL VERSUS ORBITAL ATHERECTOMY WITH MECHANISTIC INSIGHTS USING OPTICAL COHERENCE TOMOGRAPHY (2018) (1)
Reply: Risk Scores From PARIS Registry: Are They Useful in a Contemporary Cohort of ACS Patients? (2016) (1)
Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial. (2020) (1)
TCT-6 Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry (2013) (1)
Acute Coronary Syndrome (2014) (1)
Comparison of the effect of morphine and fEntanyl in patients with acute coronary syndrome - The COMET randomized controlled trial. (2021) (1)
DIFFERENCES IN CORONARY PLAQUE COMPOSITION AND MORPHOLOGY IN PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASE PRESENTING WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE PROSPECT STUDY (2011) (1)
Abstract 17291: Impact of Diabetes Mellitus on Atherosclerotic Plaque Lipid Regression: Results from the Prospective, Randomized YELLOW Trial (2012) (1)
IMPACT OF RESIDUAL INFLAMMATORY RISK IN PATIENTS WITH LOW LDL-CHOLESTEROL UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHT FROM A LARGE SINGLE-CENTER REGISTRY (2019) (1)
Tuesday, 28 August 2012 (2012) (1)
Impact of chronic kidney disease on carotid atherosclerotic plaque prevalence and morphology: results from the high-risk plaque bioimage study (2013) (1)
TCT-288 Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Intervention: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaborative Patient-Level Pooled Analysis. (2016) (1)
Correlates and Impact of Coronary Artery Calcification Visualized by Optical Coherence Tomography (2016) (1)
COMPARING PCI OUTCOMES IN THE VERY ELDERLY: DOES AGE MATTER? A REPORT FROM OUTCOMES OF SEPTUAGENARIANS, OCTOGENARIANS AND NONAGENARIANS AFTER PCI (2017) (1)
INDEPENDENT AND COMBINED IMPACT OF DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE ON PLATELET REACTIVITY (2011) (1)
IMPACT OF CHRONIC KIDNEY DISEASE ON MYOCARDIAL BLUSH AND ST-SEGMENT RESOLUTION FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION: THE HORIZONS-AMI TRIAL (2012) (1)
The Role of Aspirin After High-Risk Percutaneous Coronary Intervention: The Ticagrelor with Aspirin or Alone in High-Risk Patients After Coronary Intervention Clinical Trial Experience. (2020) (1)
SYNERGISTIC IMPACT OF CORONARY CALCIFICATION AND BIFURCATION TARGET LESIONS ON ADVERSE CARDIOVASCULAR EVENTS FOLLOWING PCI: INSIGHTS FROM A LARGE SINGLE-CENTER PCI REGISTRY (2019) (1)
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration. (2020) (1)
IMPACT OF APPROPRIATE USE CRITERIA BASED PERCUTANEOUS CORONARY INTERVENTIONS ON LONG TERM CLINICAL OUTCOMES OF PATIENTS: A LARGE VOLUME, SINGLE CENTER EXPERIENCE (2014) (1)
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial (2020) (1)
Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria (2021) (1)
The fine balance of quality and quantity: The time has come to define quality of PCI! (2011) (1)
USE OF POTENT P2Y12 INHIBITORS IN AFRICAN-AMERICAN PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES (2017) (1)
IMPACT OF BIVALIRUDIN ON ACCESS AND NON-ACCESS RELATED BLEEDING IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER REGISTRY (2012) (1)
Abstract 20850: Impact of Self-Reported Ethnicity on Response to Clopidogrel in Patients Underoing Percutaneous Coronary Intervention (2010) (1)
OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTIONS [PCI] BASED ON SEVERITY OF CORONARY ARTERY CALCIFICATION [CAC] (2014) (1)
P2068Incidence, determinant and temporal impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis (2017) (1)
Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention. (2021) (1)
TCT-539 Clinical outcomes in high bleeding risk patients undergoing complex PCI with the Xience everolimus eluting stent: a patient-level pooled analysis from four Xience post-approval trials (2018) (1)
Coronary Artery Calcification and Mortality After Revascularization: Look Beyond the Heart. (2021) (1)
TCT-221 Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study (2015) (1)
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI. (2022) (1)
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing PCI. (2022) (1)
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. (2022) (1)
A Renewed Application of Intracoronary Brachytherapy for In-Stent Restenosis of Drug-Eluting Stents (2014) (1)
Prevalence and prognostic impact of hsCRP elevation are age‐dependent in women but not in men undergoing percutaneous coronary intervention (2020) (1)
TCT-447 Real World Generalizability Of Patients Enrolled In Clinical Trials Versus Those Not Enrolled (2015) (1)
TCT-838 Prognostic Significance of a Previous Family History of Premature Coronary Artery Disease in Patients with Left Main Disease Undergoing PCI or CABG: Subgroup Analysis from EXCEL Trial (2017) (1)
TCT-486 Additive And Independent Impact Of Chronic Kidney Disease And Diabetes Mellitus On High Platelet Reactivity And Adverse Events Following PCI: Results From The ADAPT-DES Registry (2014) (1)
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative (2020) (1)
Lipid-lowering guidelines and statin use in CKD: a time for change. (2014) (1)
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease (2023) (1)
Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era. (2017) (1)
Calcific Aortic Stenosis: Pathology and Role of Balloon Aortic Valvuloplasty. (2012) (1)
WHICH GLOMERULAR FILTRATION RATE EQUATION BEST PREDICTS POOR OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY PCI: RESULTS FROM THE HORIZONS-AMI STUDY (2012) (1)
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry (2020) (1)
TEMPORARY TREND AND OUTCOME OF MECHANICAL CIRCULATORY SUPPORT IN ELECTIVE HEMODYNAMICALLY STABLE HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (2020) (1)
TCT-271 Sex-related differences in outcomes after percutaneous coronary intervention (PCI) in patients with diabetes presenting with acute coronary syndrome (ACS): Results from the PROMETHEUS study. (2016) (1)
TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (1)
TRENDS IN INCIDENCE AND MORTALITY ASSOCIATED WITH ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PCI FOR ACUTE CORONARY SYNDROME (2017) (1)
INCIDENCE OF ACUTE KIDNEY INJURY WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (1)
Predicting Risk of Ischemic or Bleeding Events After Percutaneous Coronary Intervention. (2016) (1)
IMPACT OF STENT DIAMETER ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH 2ND GENERATION DRUG ELUTING STENTS: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2018) (1)
PATTERNS OF ADHERENCE TO DUAL ANTIPLATELET THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE PARIS REGISTRY (2015) (1)
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. (2022) (1)
Educational Experience of Interventional Cardiology Fellows in the United States and Canada (2023) (1)
A simple scoring tool for the evaluation of patients in an emergency department chest pain unit. (2014) (1)
GENETIC RISK, ADHERENCE TO A HEALTHY LIFESTYLE, AND RISK OF CORONARY ARTERY DISEASE (2017) (1)
TCT-482 "Resistant" In-Stent Restenosis in the Drug-Eluting Stent Era: An Angiographic Description and Outcomes (2013) (1)
IMPACT OF SINGLE VERSUS DUAL ANTI PLATELET THERAPY ON EARLY OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE WIN-TAVI REGISTRY (2017) (1)
TCT-365 Pregnancy-Induced Disorders Identify High-Risk Women who Benefit from Cardiovascular Screening: Results from the Women's Heart Health Initiative, an OB/GYN Screening Pilot Program (2012) (1)
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft (2021) (1)
Assessment and validation of a novel fast fully automated artificial intelligence left ventricular ejection fraction quantification software (2022) (1)
P6114Characteristics and clinical outcomes in patients undergoing PCI by levels of high-density lipoproteins (2017) (1)
291 Ticagrelor monotherapy after percutaneous coronary intervention in high-risk patients with prior myocardial infarction: a prespecified twilight substudy (2021) (1)
TCT-68 Influence of Final Kissing Balloon Inflation on Long-Term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial (2019) (1)
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis. (2022) (1)
OralBleeding and the Hazards of AnticoagulationTCT-89 Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry (2017) (0)
P1652Effect of systemic inflammation and coronary artery disease complexity on outcomes after percutaneous coronary intervention (2018) (0)
DIFFERENTIAL IMPACT OF HIGH PLATELET REACTIVITY ON CLOPIDOGREL IN WOMEN AND MEN FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH DES (2015) (0)
ANGIOGRAPHIC PHENOTYPE AND CLINICAL OUTCOMES OF PATIENTS WITH MALIGNANCY UNDERGOING PCI (2017) (0)
TICAGRELOR MONOTHERAPY AFTER PCI ACROSS THE SPECTRUM OF HIGH-RISK PATIENTS: A DEEP DIVE INTO THE TWILIGHT TRIAL (2022) (0)
P1760Incidence and effects of stroke, MI and bleeding on mortality among patients with ACS undergoing PCI: a comparative analysis from the PROMETHEUS registry (2019) (0)
EFFECT OF SYSTEMIC INFLAMMATION ON OUTCOMES AFTER COMPLEX PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
TCT-362 Direct-Acting Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis (2022) (0)
Corrigendum to "Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry" [Int. J. Cardiol. 283 (2019) 67-72]. (2019) (0)
FEASIBILITY AND VALIDITY OF MEASURING PATIENT-REPORTED HEALTH STATUS AT TIME OF PCI: RESULTS FROM A SINGLE-CENTER QUALITY IMPROVEMENT INITIATIVE (2018) (0)
SEX-DIFFERENCES IN THE SAFETY AND EFFICACY OF THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY (2018) (0)
TCT-839 Prognostic Significance of Established CAD in Patients with Left Main Disease Undergoing Revascularization: Analysis from EXCEL Trial (2017) (0)
Long-term outcomes in high-bleeding risk patients undergoing PCI for acute coronary syndromes: results from a large single-center pci registry (2020) (0)
TCT-363 Increased Lipid Content, Macrophage Infiltration And Neovascularization in Culprit Coronary Lesions of Patients With Chronic Kidney Disease (2015) (0)
ALTERED CALCIFICATION MEDIATORS OF BONE MORPHOGENETIC PROTEIN–2 AND FETUIN–A PROTEIN EXPRESSION AND MEDIAL ARTERY CALCIFICATION IN PATIENTS WITH PERIPHERAL VASCULAR DISEASE, WITH OR WITHOUT DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE: IMPLICATIONS IN LESION PROGRESSION (2013) (0)
TCT-542 Impact of Baseline Anemia and Thrombocytopenia on 1-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
RISK AND IMPACT OF DIABETES MELLITUS ON ISCHEMIC EVENTS IN FEMALES AND MALES AFTER PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
PATIENT EXPERIENCE WITH DIGITAL NAVIGATION DURING CARDIAC CATHETERIZATION: EARLY FINDINGS FROM ACC DIGITAL TRANSFORMATION NETWORK PIONEER COHORT (2020) (0)
TCT-117 Impact of Discharge Location After Transcatheter Aortic Valve Replacement On 1-Year Outcomes In Women: Results From The WIN-TAVI Registry (2017) (0)
TCT-365 The relationship between intravascular ultrasound (IVUS) plaque burden and lesion characteristics by Optical Coherence Tomography (OCT): a multimodality imaging study (2015) (0)
NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY (2015) (0)
MULTIMODALITY INTRAVASCULAR IMAGING TO EVALUATE PLAQUE CHARACTERISTICS IN PATIENTS WITH DIABETES MELLITUS (2017) (0)
Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis (2022) (0)
Establishing the Safety of Intracoronary Brachytherapy for In-Stent Restenosis of Drug-Eluting Stents (2015) (0)
TCT-490 Frequency And Impact Of Nuisance Bleeding On Adverse Events After Percutaneous Coronary Intervention: 2-Year Results From The Patterns Of Non-Adherence To Antiplatelet Regimens In Stented Patients (PARIS) Registry (2014) (0)
Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease (2018) (0)
Chronic total occlusions (2021) (0)
P1664Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration (2018) (0)
TCT-112 Impact of Race/Ethnicity On 30 Day Readmission After Percutaneous Coronary Intervention: Results From a Multiethnic, Single Center Registry (2014) (0)
PERFORMANCE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA ACCORDING TO SEX (2020) (0)
DAPT Duration After DES (0)
TCT-6 Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 inhibitors in Contemporary PCI: Results from a Large Single-Center Registry. (2016) (0)
Switching Between Intravenous and Oral P2Y12 Inhibition: Easier Said Than Done. (2023) (0)
JAMA Cardiology List of Peer Reviewers. (2017) (0)
TCT-268 Impact of diabetes on outcomes after percutaneous coronary intervention in patients according to race/ethnicity. (2016) (0)
TCT-222 Combined and independent impact of diabetes mellitus and chronic kidney disease on clinical outcomes by SYNTAX score in patients undergoing PCI (2017) (0)
Abstract WP171: Predictors and Outcomes of Stroke After Trans-Catheter Aortic Valve Replacement in the United States, 2012-2014 (2018) (0)
TCT-335 Impact of Age on Sex-Based Differences on Cardiovascular Risk Between Men and Women Undergoing PCI: Results from a Large Single-Center Registry with Over 18,000 Patients. (2016) (0)
Distribution of ancestry in each cohort. (2020) (0)
ROTATIONAL VERSUS ORBITAL ATHERECTOMY FOR TREATMENT OF DIFFUSE CORONARY IN-STENT RESTENOSIS (2020) (0)
A NOVEL APPROACH TO IDENTIFY WOMEN WITH CARDIOVASCULAR RISK FACTORS: RESULTS FROM THE OB/GYN SCREENING PILOT PROGRAM (2012) (0)
Impact of high-density lipoprotein levels in males and females undergoing percutaneous coronary intervention with drug eluting stents (2020) (0)
P493Impact of prior cerebrovascular diseases on treatment strategies and clinical outcomes after percutaneous coronary interventions (2017) (0)
Exercise Physiology in the Cath Lab: Still Alive and Well! (2012) (0)
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Less Is Not Always More. (2022) (0)
TCT-249 Differential Impact Of Diabetes Mellitus On Safety And Efficacy Of New Versus First Generation Drug-eluting Stents Among Women: A Patient-level Pooled Analysis Of 26 Randomized Trials (2014) (0)
Abstract 21201: Stent Length Remains an Important Risk for Recurrent Events in Women With or Without Diabetes Mellitus After New Generation DES PCI: From the WIN DES Collaboration (2017) (0)
Abstract 19124: Detection and Prevalence of Systemic Atherosclerosis: Results from the High-Risk Plaque (HRP) Initiative (2012) (0)
NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY (2015) (0)
IMPACT OF ARTERIAL ACCESS SITE ON RISK FOR ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PCI: RESULTS FROM A LARGE SINGLE-CENTER PCI REGISTRY (2015) (0)
Abstract 5015: Thrombolysis in Myocardial Infarction (TIMI) Risk Score and Mortality in Patients with Advanced Chronic Kidney Disease (CKD) and on Dialysis (2008) (0)
Ticagrelor with or without Aspirin after PCI. Reply. (2020) (0)
TEMPORAL TRENDS, DETERMINANTS AND IMPACT OF HIGH-INTENSITY LIPID LOWERING THERAPY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2018) (0)
Reply: "Zero": The New Superhero or Superhero in Training? (2019) (0)
P1663COMBO stent PCI for elderly patients: one year clinical outcomes and DAPT cessation patterns from the global MASCOT registry (2018) (0)
TCT-221 Predictors of optimal medical therapy on discharge after percutaneous coronary intervention for acute coronary syndrome: An analysis of the PROMETHEUS registry. (2016) (0)
CLASSIFYING PLAQUES ACCORDING TO LIPID CONTENT AS ASSESSED BY NEAR INFRARED SPECTROSCOPY: IMPLICATIONS FOR PLAQUE VULNERABILITY (2015) (0)
the and impact of risk scores on long-term outcomes in CKD patients. MitraClip in High- Versus Low-Volume Centers (2018) (0)
Abstract 13775: Dual vs. Triple Antithrombotic Therapy After Coronary Stenting in Patients With Non-Valvular Atrial Fibrillation (2013) (0)
STATIN USE IN RELATION TO SOCIAL DETERMINANTS OF HEALTH AMONG UNITED STATES ADULTS - TEMPORAL TRENDS OVER 20 YEARS (2022) (0)
TCT-834 Coronary Plaque Vulnerability in Statin Treated Patients With Elevated LDL-C and hs-CRP: Optical Coherence Tomography Study (2019) (0)
TCT-471 Impact of New- versus Early-Generation Drug Eluting Stents in Women according to Age: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (0)
Impact of Frailty on In-Hospital Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Occlusion. (2023) (0)
Treating Myocardial Ischemia Before Kidney Transplantation: Time for a Reappraisal. (2021) (0)
COUNTERING THE ANTI-PLATELET EFFECTS OF TICAGRELOR WITH PLATELET CONCENTRATES WITHIN 48 HOURS OF A LOADING DOSE: EX VIVO TESTING OF TIME-EFFECT ON FUNCTIONAL RECOVERY IN PATIENTS WITH CARDIOVASCULAR DISEASE (2017) (0)
BLEEDING RISK IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2021) (0)
Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions: The ORBID‐FFR study (2020) (0)
Antiplatelet and Antithrombotic Therapy in Percutaneous Coronary Interventions (2021) (0)
IMPACT OF HEMODIALYSIS AND HIGH PLATELET REACTIVITY ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY (2014) (0)
TCT-237 Efficacy and Safety of Routine Thrombus Aspiration in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: an updated Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015) (0)
Abstract 18591: Anatomically- Versus Clinically-derived Risk Scores Have Markedly Differing Predictive Abilities Following PCI For Multivessel CAD: The "TLR Paradox" (2012) (0)
COMPARATIVE INCIDENCE AND COSTS ASSOCIATED WITH 30-DAY READMISSION FOR RECURRENT MI VERSUS MAJOR BLEEDING AMONG PATIENTS HOSPITALIZED WITH ACUTE MI IN THE UNITED STATES: A POPULATION-BASED COHORT STUDY (2020) (0)
P1661Evaluation of transradial versus transfemoral procedures in all-comers patients treated with the dual-therapy stent (2018) (0)
USE OF ANGIOVAC FOR DEBULKING TRICUSPID VALVE VEGETATIONS IN A PATIENT WITH A PATENT FORAMEN OVALE (2021) (0)
PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 PROTEIN EXPRESSION IS INCREASED IN LIPID RICH HUMAN ATHEROSCLEROTIC PLAQUES COMPARED TO FIBROUS PLAQUES (2017) (0)
P2262Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials (2018) (0)
P3100 | BEDSIDE Endothelial dysfunction versus early atherosclerosis: a study with high resolution imaging (2015) (0)
D-37 | Racial Disparities in the Utilization and Outcomes of Percutaneous Left Atrial Appendage Occlusion in the United States (2022) (0)
Rationale and Technique for Percutaneous Coronary Intervention of Chronic Total Occlusions (2015) (0)
Abstract 15275: Altered Extracellular Matrix Proteoglycan- Decorin, Collagens and Elastin Deposition May Enhance Atherosclerosis in Human Peripheral Artery Disease: Implication of Morphological Predictors in Restenotic Plaque Progression (2015) (0)
Abstract 17007: Does Age Modify Gender-based Differences in Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) (2014) (0)
IMPACT OF HIGH DOSE ASPIRIN IN MEN VS. WOMEN AFTER ACUTE MYOCARDIAL INFARCTION: RESULTS FROM THE HORIZONS-AMI TRIAL (2012) (0)
Abstract 19521: Impact of Procedural Complications on Survival in Patients with Severe Aortic Stenosis Treated with Balloon Aortic Valvuloplasty: Results from the BRAVO Study (2012) (0)
TCT-205 Incidence and clinical outcomes associated with DAPT discontinuation in complex PCI patients: From the PARIS registry. (2016) (0)
P511Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry (2017) (0)
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation. (2019) (0)
OC10_02 Impact of Diabetes Mellitus on Patients With Human Immunodeficiency Virus Undergoing Percutaneous Coronary Intervention: Results From a Large, Single Center Registry (2016) (0)
ADDITIVE EFFECT OF MULTIPLE HIGH BLEEDING RISK CRITERIA IN PATIENTS UNDERGOING PCI (2020) (0)
Abstract 18677: The ACEF Risk Score Exhibits Superior Predictive Ability for Adverse Clinical Outcomes in Women Undergoing PCI (2012) (0)
USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING (2016) (0)
TCT-838 Prognostic Value of High-Sensitivity C-Reactive Protein in Percutaneous Coronary Intervention According to Body Mass Index (2019) (0)
ATHEROSCLEROTIC PLAQUE MORPHOLOGY IN RESPONSE TO HIGH INTENSITY LIPID LOWERING THERAPY BY MULTIMODALITY IMAGING AMONG WOMEN AND MEN: A YELLOW-II SUB-STUDY (2017) (0)
ASSOCIATIONS BETWEEN VALVE TYPE AND OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE WIN-TAVI REGISTRY (2018) (0)
TCT-858 Residual inflammatory status in patients with stable coronary artery disease undergoing percutaneous coronary intervention (2018) (0)
TCT-304 Long term clinical outcomes in acute coronary syndrome patients at high bleeding risk undergoing PCI with implantation of everolimus-eluting stents: Results from the Patient-Level Pooled Analysis of EES Post Approval Studies. (2018) (0)
TRENDS IN UPTAKE AND IN-HOSPITAL OUTCOMES WITH 2ND GENERATION DRUG ELUTING STENTS BETWEEN MEN AND WOMEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM THE CATHPCI REGISTRY (2014) (0)
TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. (2016) (0)
COMPARISON OF WARFARIN VS DIRECT ORAL ANTICOAGULANTS AFTER LEFT ATRIAL APPENDAGE OCCLUSION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
PREDICTORS OF NET ADVERSE CLINICAL EVENTS POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY (2012) (0)
TCT-541 Validation of the Academic Research Consortium–High Bleeding Risk Criteria for Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
Abstract 15502: Clinical Outcomes in Patients Undergoing Non-cardiac Surgery Within 1 Year of Pci (2020) (0)
SAFETY AND EFFICACY OF THE BIOABSORBABLE POLYMER EVEROLIMUS ELUTING STENTS COMPARED TO THE 2ND GENERATION DURABLE POLYMER EVEROLIMUS ELUTING STENTS IN COMPLEX CORONARY LESIONS (2019) (0)
TCT-379 Independent and Combined Effect of Chronic Kidney Disease and Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry. (2022) (0)
PM207 Severe Coronary Artery Atherosclerosis Burden Among South Asians and Hispanics Undergoing PCI as Compared to Non-Hispanic Whites (2016) (0)
THE RELATIONSHIP BETWEEN PERICARDIAL ADIPOSE TISSUE VOLUME, ATHEROSCLEROTIC PLAQUE TYPE AND CARDIOVASCULAR RISK: A HIGH RISK PLAQUE BIOIMAGE SUB-STUDY (2017) (0)
TCT-72 Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV trials (2012) (0)
Abstract 16507: Complex Percutaneous Coronary Intervention Features Worsen Prognosis in Diabetic Patients: Insights From a Large Single-center Registry (2020) (0)
Erratum to: A comparison of coronary CTA and stress testing using high-efficiency SPECT MPI for the evaluation of chest pain in the emergency department (2014) (0)
761 PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY (2022) (0)
Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention (2022) (0)
Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single‐center registry (2020) (0)
Reply: P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent. (2020) (0)
CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS (2014) (0)
TCT-219 Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study (2015) (0)
Abstract 20162: Comparision of Procedural and 30 Day Outcomes of Roataional vs Orbital Atherectomy in Severely Calcified Coronary Lesions (2014) (0)
Abstract 10647: Translational Systems Genetics, Electronic Medical Record Analysis, and Molecular Imaging Reveal That the Antidepressant Trazodone Reduces Atherosclerosis as Well as Statins: Drug Discovery by Repurposing of Proven Safe Drugs (2018) (0)
Coronary plaque vulnerability in statin-treated patients with elevated LDL-C and hs-CRP: optical coherence tomography study (2022) (0)
TCT-747 Associations between Stent Diameter and Clinical Outcomes in ACS PCI Using Second Generation Drug-Eluting Stents: From the PROMETHEUS Study (2017) (0)
Abstract 20415: Incidence of Post-Procedural Myocardial Infarction and Risk of Recurrent Cardiac Events After Coronary Stenting (2016) (0)
VARIABILITY OF ANTIPLATELET EFFECT WITH TICAGRELOR VERSUS CLOPIDOGREL IN DIABETIC PATIENTS (2016) (0)
INCIDENCE, PREDICTORS AND IMPACT OF STROKE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES: RESULTS FROM THE PROMETHEUS REGISTRY (2016) (0)
Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy (2021) (0)
Racial and ethnic differences in severity of coronary calcification among patients undergoing PCI: Results from a single-center multiethnic PCI registry (2021) (0)
TCT-400 Everolimus-Eluting Stent and Dedicated 2-Stent Strategy in Complex 'True' Bifurcation Lesion with Major Side Branch Involvement (2013) (0)
4284Impact of coronary artery disease and PCI on Long-term outcomes of women undergoing transcatheter aortic valve replacement: insights from the multi-center WIN-TAVI registry (2018) (0)
TCT-886 Predictors of Vascular complications in patients undergoing Balloon Aortic Valvuloplasty (2012) (0)
Abstract 17741: Atrial Fibrillation and Incident End-Stage Renal Disease: the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2014) (0)
Abstract 11515: Does Prolonged Dual Antiplatelet Therapy Increase Mortality After Drug-Eluting Stent Implantation? (2015) (0)
Side branch FFR after provisional stenting: simplified approach based on OCT frame count (2020) (0)
A NOVEL MOBILE APPLICATION TO DIAGNOSE AND TRANSFER PATIENTS WITH STEMI IN A LARGE HEALTHCARE SYSTEM: STEMICATHAID (2021) (0)
TCT-475 Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (0)
Ischemia vs Bleeding: The Case of Customized DAPT (2019) (0)
RISK-TREATMENT PARADOX IN PREVALENCE AND DETERMINANTS OF POTENT P2Y12 INHIBITOR USE IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2016) (0)
TCT-642 PARIS Risk Score Stratified Analysis of Clinical Outcomes Among Elderly Patients (Aged > 75 Years) Treated With 23-Month Ticagrelor Monotherapy Following 1-Month DAPT After PCI in the GLOBAL LEADERS Trial (2019) (0)
TCT-451 Incidence, Correlates and impact of left ventricular ejection fraction improvement on short- and long-term clinical outcome of patients undergoing high-risk percutaneous coronary intervention. A single center experience (2018) (0)
P6138Quality of clinical trial evidence on devices and drugs approved to treat coronary artery disease (2019) (0)
TCT-477 Major Adverse Cardiovascular Events And Bleeding Risk Analysis In Elderly Afibrillation Patients Undergoing Percutaneous Coronary Intervention: The AVIATOR Registry (2014) (0)
TCT-278 Clinical Outcomes of All-Comer Patients Presenting With Acute Coronary Syndrome Treated With the COMBO Stent: From the MASCOT and REMEDEE Registry (2019) (0)
P2331Association between serum osmolality and acute kidney injury after percutaneous coronary intervention: a simple tool for acute kidney injury prediction (2017) (0)
P4554Impact of the presence of chronic kidney disease on 1-year target lesion failure in patients treated with a dual-therapy stent (2018) (0)
TCT-844 Long term risk for major bleeding and ischemic events after PCI with implantation of everolimus-eluting stents: A Pooled-level Analysis of 8,020 Patients (2018) (0)
IMPACT OF BODY MASS INDEX ON MAJOR BLEEDING AFTER PCI: ONE-YEAR RESULTS FROM THE MULTICENTER PROSPECTIVE PARIS REGISTRY (2013) (0)
Abstract 16973: Prevalence, Determinants, and Impact of Target Lesion Calcification in Patients Undergoing Percutaneous Coronary Intervention With Newer Generation Drug Eluting Stents: Findings From a Large Multiethnic Registry (2015) (0)
Prevention of stroke in patients with atrial ﬁbrillation: current strategies and future directions (2008) (0)
DIFFERENTIAL IMPACT OF FEMALE GENDER ON MORTALITY BY PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE FOLLOWING PCI: RESULTS FROM A SINGLE–CENTER REGISTRY WITH 15,990 PATIENTS (2013) (0)
Managing Anticoagulation in Patients with Mechanical Valves (2014) (0)
Abstract 16974: Gender Differences in Patients Undergoing Transcatheter Aortic Valve Replacement: a Single Center Experience (2014) (0)
Ticagrelor With or Without Aspirin in High-Risk Patients With Anemia Undergoing Percutaneous Coronary Intervention: a subgroup analysis of the TWILIGHT trial. (2023) (0)
TCT-438 Impact of concomitant coronary artery disease on risk for short-term MACCE in patients after TAVR (2017) (0)
TCT-798 Evaluation of sex-differences in one-year clinical outcomes among patients treated with the dual-therapy COMBO stent: From the COMBO Collaboration (2018) (0)
Impact of dual antiplatelet non-adherence after percutaneous coronary intervention in patients with or without history of myocardial infarction (2021) (0)
SODIUM NITROPRUSSIDE AS A BRIDGE TO TAVR IN SEVERE AORTIC STENOSIS COMPLICATED BY CARDIOGENIC SHOCK (2023) (0)
TCT-662 Patients Who Do Not Receive Drug-Eluting Stent for In-Stent Restenosis: Characteristics and Outcomes (2019) (0)
Pharmacology/PharmacotherapyTCT-220 Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study (2015) (0)
TCT-163 Do Patients with Paroxysmal Atrial Fibrillation in Sinus Rhythm during PCI Require Triple Therapy? Results from a Multicenter Center Study (2013) (0)
Reply: Research and Therapeutic Nihilisms in Chronic Kidney Disease. (2017) (0)
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight. (2023) (0)
PROMETHEUS: Clinical Profiles Differ in ACS Patients Treated With Prasugrel and Clopidogrel (2015) (0)
TCT-417 Influence of Thrombotic and Bleeding Risk on P2Y12 Receptor Inhibitor Choice in ACS After PCI: Insights From a Large Single-Center Registry (2019) (0)
GLOBAL UTILIZATION OF A NOVEL APP-BASED LEARNING PLATFORM FOR CLINICAL EDUCATION IN INTERVENTIONAL CARDIOLOGY (2023) (0)
Abstract 19548: Detection, Correlation and Prediction of Systemic Vascular Disease using 3D volumetric Carotid Ultrasound: Results from the High Risk Plaque Initiative (2012) (0)
Left Main PCI With DES Versus CABG (2018) (0)
TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention with Drug Eluting Stents. (2020) (0)
Abstract 20664: Is Aspirin Needed as an Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Coronary Intervention? (2017) (0)
CRT-100.06 Differences in Quantitative Coronary Angiographic (QCA) Characteristics of Coronary Artery Disease and Clinical Outcomes Between Statin Pre-treated and Statin-Naïve Human Immunodeficiency Virus (HIV) Patients Undergoing Percutaneous Coronary Intervention (PCI) (2017) (0)
Effects of Body Mass Index on ClinicalOutcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (2017) (0)
TCT-827 Relationship Between Hemoglobin A1C and Coronary Plaque Vulnerability in Patients Undergoing Percutaneous Coronary Intervention: An Optical Coherence Tomography Study (2019) (0)
Meta-Analysis of Anticoagulation Therapy for the Prevention of Cardiovascular Events in Patients with Peripheral Arterial Disease. (2021) (0)
PREVALENCE AND PROGNOSTIC IMPACT OF HIGH BLEEDING RISK STATUS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN CORONARY ARTERY DISEASE (2021) (0)
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: insights from a large PCI registry. (2023) (0)
TCT-217 Efficacy of Dual Antiplatelet Therapy in Women with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015) (0)
IMPACT OF BODY SURFACE AREA ON OUTCOMES IN WOMEN AND MEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
TCT-110 Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry (2018) (0)
SYNERGISTIC EFFECTS OF CORONARY CALCIFICATION AND INFLAMMATION ON RISKS FOR ADVERSE CARDIOVASCULAR EVENTS AFTER PCI: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2017) (0)
Bleeding Associated with Angiography and Percutaneous Coronary Intervention (2018) (0)
IMPACT OF AGE ON THE MODES OF DUAL ANTIPLATELET THERAPY CESSATION: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2015) (0)
TCT-397 Edoxaban versus Standard of Care and their Effects on Clinical Outcomes in Patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation – Rationale and Design of the ENVISAGE-TAVI AF Trial (2017) (0)
Repurposing the atypical antidepressant trazodone for atherosclerotic cardiovascular disease (2021) (0)
CLINICAL OUTCOMES BY SEX AND ETHNICITY AFTER PERCUTANEOUS CORONARY INTERVENTION (2018) (0)
Abstract 19575: Mortality Risk of Prolonged Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Bayesian Cross-Design Meta-Analysis of Completed and Prematurely Stopped Trials (2016) (0)
ASSOCIATIONS BETWEEN DIFFERENT MODES OF DAPT CESSATION AND MAJOR ADVERSE EVENTS AT 6 MONTHS AND BEYOND: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
Abstract 15109: Racial Variability in Severity of Coronary Calcification Among Patients Undergoing Percutaneous Coronary Intervention: Results From a Single-Center Multiethnic Registry (2019) (0)
TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. (2016) (0)
TCT-105 Prevalence of prasugrel use and associations between type of acute coronary syndrome and 1-year clinical outcomes. (2016) (0)
TCT-285 Stent Diameter and Clinical Outcomes After PCI: From the COMBO MASCOT and REMEDEE Collaboration (2019) (0)
TCT-485 Effect of Gender on Clinical Outcomes in Patients With or Without Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Results from a Large Single Center Registry (2015) (0)
Abstract 12569: Analysis of Deep Learning Models for Prediction of Heart Failure Mortality (2020) (0)
IMPACT OF VASCULAR CLOSURE WITH THE PRE-CLOSURE TECHNIQUE ON ADVERSE EVENTS IN PATIENTS UNDERGOING TRANSFEMORAL BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER registry (2012) (0)
TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. (2016) (0)
IMPACT OF ACUTE KIDNEY INJURY ON OUTCOMES IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY (2013) (0)
Intersection of the Academic Research Consortium – high bleeding risk criteria in patients undergoing PCI for acute coronary syndromes: insights from a high-volume single centre registry (2020) (0)
TCT-496 Differences in quantitative coronary angiographic (QCA) characteristics of coronary artery disease between Human Immunodeficiency Virus (HIV) patients presenting with acute coronary syndrome (ACS) and stable angina pectoris (SAP) undergoing percutaneous coronary intervention (PCI). (2016) (0)
TCT-218 Balancing The Risk Between Myocardial Infarction and Clinically Significant Bleeding With Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation (2015) (0)
TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY (2021) (0)
Abstract 21306: Impact of Insulin Treated Diabetes Mellitus on 1 Year Outcomes After Contemporary PCI (2017) (0)
TCT-56 Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results from a Large Single-Center Registry. (2016) (0)
Stent Expansion and Endothelial Shear Stress in Bifurcation Lesions. (2019) (0)
Abstract 3866: Predictors of Coronary Atherosclerosis Differ Between Patients with and without Chronic Kidney Disease (2006) (0)
Abstract 16570: Systemic Inflammation Alters the Bleeding-Ischemic Balance in High-Bleeding Risk Patients Undergoing Percutaneous Coronary Interventions (2020) (0)
ISCHEMIA Trial: Not so Fast, More Questions than Answers (2019) (0)
PLAQUE MORPHOLOGY PREDICTORS OF SIDE BRANCH OCCLUSION AFTER MAIN VESSEL STENTING IN CORONARY BIFURCATION LESION: OPTICAL COHERENCE TOMOGRAPHY IMAGING STUDY (2016) (0)
PROGNOSTIC VALUE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PCI (2021) (0)
P2069Multivessel PCI versus culprit-vessel only PCI in patients with acute myocardial infarction and multivessel disease (2017) (0)
Duration of Dual Antiplatelet Therapy AfterDrug-Eluting Stent Implantation (0)
Are the minor high bleeding risk criteria of the academic research consortium truly minor? Insights from a high-volume tertiary care pci centre (2020) (0)
Reply: Chronic Kidney Disease and Antiplatelet Therapy: A Worrying Gap Between Evidence Based Medicine and Clinical Practice. (2018) (0)
Future Perspectives on Percutaneous Coronary Interventions in Women. (2012) (0)
The 5W1H in antiplatelet monotherapy after percutaneous coronary intervention: what, who, where, when, why, and how? (2021) (0)
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
PREDICTORS OF HIGH INTENSITY STATIN USE AFTER PERCUTANEOUS CORONARY INTERVENTIONS (2017) (0)
TCT-565 Long-term Outcomes and Predictors Of Adverse Events After Successful Saphenous Vein Graft Intervention. Results from A Large Single-Center (2017) (0)
Abstract 18908: Transcutaneous Aortic Valve Replacement - 30 Day and 1 Year Outcomes Using Conscious Sedation in Patients Stratified by STS Risk Score (2014) (0)
IMPELLA OR INTRA-AORTIC BALLOON PUMP SUPPORT IN PATIENTS UNDERGOING HIGH RISK PERCUTANEOUS CORONARY INTERVENTION: A REAL WORLD SINGLE CENTER EXPERIENCE (2017) (0)
Optimal Antithrombotic Therapy after Drug-eluting Stent Implantation in Patients with Atrial Fibrillation (2017) (0)
TCT-111 Gender Differences In The Burden Of Coronary Artery Disease In Patients With Human Immunodeficiency Virus Infection Undergoing Percutaneous Coronary Intervention (2014) (0)
CLINICAL OUTCOMES ASSOCIATED WITH IMPELLA VERSUS IABP USE IN STABLE PATIENTS UNDERGOING HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
Periprocedural Myocardial Infarction: Is the Debate Over? (2023) (0)
TCT-401 Associations Between Baseline Atrial Fibrillation And Risk Of 1-Year Outcomes After Transcatheter Aortic Valve Replacement: Results From The WIN-TAVI Registry (2017) (0)
Association of MARC1 A165T with metabolic traits. (2020) (0)
Abstract 15867: Contemporary Percutaneous Treatment of In-Stent Restenosis in the United States: Insights From a Large Single-Center Registry (2018) (0)
TCT-398 Associations Between Atrial Fibrillation and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement With Self-Expanding Devices: Results From the United States STS/ACC TVT Registry (2017) (0)
THE EFFECT OF COMPLEX CORONARY REVASCULARIZATION PROCEDURE IN PATIENTS AT HIGH-BLEEDING RISK (2020) (0)
TCT-123 Incidence and Impact of Acute Kidney Injury in Patients with Acute Coronary Syndromes Treated with CABG: Insights from ACUITY/HORIZONS-AMI (2014) (0)
Reply: DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration? (2019) (0)
DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2019) (0)
Abstract 11314: Inverse Relationship Between Body Mass Index and Coronary Artery Calcification in Older Patients with Clinically Significant Coronary Lesions (2011) (0)
AVIATOR-2: Antithrombotic Strategy Variability in Atrial Fibrillation and Obstructive Coronary Disease Revascularized with Percutaneous Coronary Intervention Registry (2019) (0)
EFFECTIVE EVALUATION OF PATIENTS IN AN EMERGENCY DEPARTMENT CHEST PAIN UNIT WITH MYOCARDIAL PERFUSION IMAGING (2011) (0)
UNDERUTILIZATION OF HIGH INTENSITY STATINS IN A CONTEMPORARY HIGH RISK PCI POPULATION (2017) (0)
TCT-414 Dedicated 2-stent versus 1-Stent Strategy in Diabetic Patients with Complex 'True' Bifurcation Lesion PCI using Everolimus-Eluting Stent (2013) (0)
IMPACT OF POTENT P2Y12 INHIBITOR USE VERSUS CLOPIDOGREL IN REAL-WORLD PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2016) (0)
CORONARY ARTERY DISEASE BURDEN AND CLINICAL OUTCOMES IN PATIENTS WITH HUMAN IMMUNE DEFICIENCY VIRUS (HIV) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A SINGLE-CENTER REGISTRY (2014) (0)
REAL-TIME 3-D ECHO GENERATED VOLUME/TIME CURVES: COMPARISON TO MAGNETIC RESONANCE IMAGINING AND INTEROBSERVER CORRELATION (2011) (0)
IMPACT OF PERCUTANEOUS CORONARY INTERVENTION COMPLEXITY IN REAL-WORLD PRACTICE (2019) (0)
Registry-based evidence generation in Middle Eastern patients undergoing PCI: a Jordanian case study examining CKD. (2019) (0)
TCT-528 Use of guideline directed medical therapy and outcomes in patients with high risk of bleeding undergoing percutaneous coronary intervention in contemporary clinical practice (2017) (0)
Wednesday, 29 August 2012 (2012) (0)
PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY (2019) (0)
Abstract 1571: Association of Chronic Kidney Disease With Atrial Fibrillation in the United States (2009) (0)
Coronary artery disease burden and long-term outcomes in patients with human immune deficiency virus (HIV) undergoing percutaneous coronary intervention: results from a single-center registry (2013) (0)
TCT-149 Impact of Chronic Kidney Disease on Myocardial Infarct Size and Adverse Events in ST-Elevation Myocardial Infarction: Results from the INFUSE-AMI Trial (2012) (0)
Abstract 12053: Incidence, Characteristics and Predictors of In-Hospital Mortality in Patients With Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction: A National Population Based Cohort Study (2018) (0)
STENT EXPANSION AND ENDOTHELIAL SHEAR STRESS IN BIFURCATION LESION: COMPARISON OF KISSING BALLOON INFLATION AND PROXIMAL OPTIMIZING TECHNIQUE (2019) (0)
Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study (2022) (0)
TCT-479 Impact of Angiographic Patterns (Focal vs. Diffuse) of Resistant In-stent Restenosis on Clinical Outcomes (2013) (0)
EFFECT OF BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN IN TRANSCATHETER AORTIC VALVE REPLACEMENT WITH SELF-EXPANDING VALVES: FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (0)
TCT-746 Outcomes by Total Stent Length in ACS PCI with Second Generation Drug-Eluting Stents: Results from the PROMETHEUS Study (2017) (0)
PROGNOSTIC VALUE OF HIGH SENSITIVITY C-REACTIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2022) (0)
One‐year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration (2020) (0)
Abstract 18702: Obesity Paradox in Women Undergoing Percutaneous Coronary Intervention With Drug-eluting Stents: Results From a Patient-level Pooled Analysis of Randomized Controlled Trials (2015) (0)
ASSOCIATION BETWEEN ORBITAL OR ROTATIONAL ATHERECTOMY AND CLINICAL OUTCOMES AMONG PATIENTS WITH CALCIFIC CORONARY ARTERY DISEASE: INSIGHTS FROM THE CLINICAL ASSESSMENT, REPORTING AND TRACKING (CART) PROGRAM (2020) (0)
Abstract 16110: Impact of Institutional Volume on In-hospital Mortality and Resource Utilization Among Patients With Pulmonary Embolism Treated With Catheter Directed Thrombolysis: A Population-Based Cohort Study (2020) (0)
TCT-476 Antithrombotic Therapy In Patients With Chronic Kidney Disease And Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Results From The AVIATOR Registry (2014) (0)
TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry. (2016) (0)
E-1 | In-hospital Outcomes after Percutaneous Coronary Intervention in Patients with Connective Tissue Disorders in the United States (2022) (0)
ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY (2018) (0)
TCT-620 Shift Of Patient Selection For Balloon Aortic Valvuloplasty After Introduction Of Transcatheter Aortic Valve Replacement: Insights From A Single-center Registry (2015) (0)
CAUSES AND IMPACT OF PREMATURE INTERRUPTION OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACTIVE CANCER (2018) (0)
TEMPORAL TRENDS IN TRANSRADIAL ACCESS DURING PCI IN RELATION TO BLEEDING RISK: INSIGHTS FROM A LARGE SINGLE-CENTER REGISTRY (2020) (0)
TCT-474 Triple vs. Dual Antithrombotic Therapy In Patients With Atrial Fibrillation And Acute Coronary Syndromes: The AVIATOR Registry (2014) (0)
Acute coronary syndromes: Antithrombotics in ACS—moving beyond unfractionated heparin (2011) (0)
TCT-577 Early- Versus New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: Results froma Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
TCT-446 Outcomes Among Patients Enrolled Versus Not Enrolled In Interventional Cardiovascular Clinical Trials: Insights From A Single-center Analysis (2015) (0)
Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies? (2017) (0)
Abstract 20886: Impact of Pre-Dialysis Chronic Kidney Disease on Response to Clopidogrel in Patients Undergoing Coronary Angiography (2010) (0)
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes (2017) (0)
INCIDENCE, PATTERNS AND ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND RISK FOR ADVERSE EVENTS IN HIGH-RISK PATIENTS: INSIGHTS FROM THE PARIS REGISTRY (2018) (0)
Abstract 15180: Impact of the Everolimus-Eluting Stent on Stent Thrombosis According to Baseline Risk of Study Population (2011) (0)
A-54 | Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis (2022) (0)
TCT-630 The Impact of Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention With a Drug Eluting Stent for Unprotected Left Main Stenosis (2019) (0)
Angiography and QCA (TCT-84 to TCT-93)TCT-87 Frequency And Impact Of Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention In Women Compared To Men: Pooled Analysis From The ACUITY And HORIZONS-AMI Trials (2014) (0)
EFFICACY AND SAFETY OF FIRST GENERATION VERSUS NEWER GENERATION DRUG-ELUTING STENTS IN PATIENTS WITH DIABETES: A DIRECT COMPARISON META-ANALYSIS OF 8,438 PATIENTS FROM RANDOMIZED TRIALS (2016) (0)
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention. (2022) (0)
SYNERGISTIC IMPACT OF CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS ON PERIPHERAL VASCULAR ATHEROSCLEROTIC PLAQUE NEOVASCULARIZATION AND INFLAMMATION (2012) (0)
TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry (2019) (0)
P2646COMBO PCI outcomes in patients categorized by baseline PARIS bleeding risk score: from the global MASCOT registry (2018) (0)
Off-Label Use of Non-Vitamin K Antagonist Oral Anticoagulants (2017) (0)
TCT-736 Prevalence and Impact of Bleeding Determinants on Risks for out-of-hospital bleeding and coronary thrombosis in patients undergoing percutaneous coronary intervention: Results from a large single-center PCI Registry (2018) (0)
TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry (2019) (0)
TCT-658 Neurologic Outcomes with Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2016) (0)
Reply: Percutaneous Coronary Intervention Outcomes According to HbA1c Levels. (2021) (0)
TCT-831 Identification of High-Risk Plaques by Coronary Angiography: Confirmation of Computational Fluid Dynamics by Optical Coherence Tomography (2019) (0)
ANTITHROMBOTIC POTENCY OF TICAGRELOR VERSUS CLOPIDOGREL, WHEN ADMINISTERED WITH BIVALIRUDIN (2014) (0)
PROGNOSTIC VALUE OF ELEVATED C-REACTIVE PROTEIN AMONG DIABETIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2021) (0)
RACIAL DIFFERENCES IN PREVALENCE OF CAROTID ATHEROSCLEROSIS: RESULTS FROM THE PLAQUE BIOIMAGE STUDY (2013) (0)
OPTICAL COHERENCE TOMOGRAPHY OF CULPRIT LESIONS IN PATIENTS WITH PRIOR CEREBROVASCULAR EVENTS COMPARED TO CONTROLS (2017) (0)
Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study (2021) (0)
Abstract 18793: Impact of Chronic Kidney Disease on Outcomes in Patients Undergoing Balloon Aortic Valvuloplasty: Results from the BRAVO Study (2012) (0)
A genome-wide association study identifies novel genetic loci associated with pulmonary embolism (2020) (0)
PREDICTION OF ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING CORONARY INTERVENTION USING CALCULATION OF SERUM OSMOLALITY (2017) (0)
Extending the aspirin-free paradigm to patients with acute coronary syndrome: is it time to change guidelines? (2020) (0)
TCT-260 Which is the Ideal Revascularization Strategy in Patients Presenting with Acute Coronary Syndrome and Proximal LAD Stenosis? Results from the ACUITY Study (2013) (0)
P6435Impact of persistent high C-reactive protein levels on all-cause mortality in patients after percutaneous coronary interventions (2018) (0)
MULTIMODALITY INTRAVASCULAR IMAGING TO EVALUATE GENDER DIFFERENCES IN PLAQUE MORPHOLOGY IN STABLE CORONARY ARTERY DISEASE (2016) (0)
TCT-380 Outcomes of Patients with Acute Myocardial Infarction in Moderate to Severe Chronic Kidney Disease in the United States. (2016) (0)
TCT-833 Inflammatory Risk Status Is Age-Dependent in Women but Not in Men Undergoing Percutaneous Coronary Intervention (2019) (0)
Asymptomatic Large Thrombus Formation in Drug-Eluting Stent 2 Days After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patient. (2017) (0)
Marcadores de riesgo negativos para eventos cardiovasculares en ancianos (2020) (0)
ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND MACE DUE TO STOPPING ONE OR BOTH DRUGS: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
Ticagrelor in Patients With Cancer (2020) (0)
MULTIVESSEL VERSUS CULPRIT-ONLY PCI IN PATIENTS WITH NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL DISEASE: RESULTS FROM THE PROMETHEUS STUDY (2017) (0)
Choice of Stents and Clinical Outcomes in Patients with Chronic Kidney Disease (2020) (0)
AMPHETAMINE INDUCED SPONTANEOUS CORONARY ARTERY DISSECTION PRESENTING AS ST-ELEVATION MYOCARDIAL INFARCTION (2023) (0)
TCT-481 Treatment of "resistant" in-stent restenosis in the drug-eluting era: comparison of repeat stent versus balloon only strategy (2013) (0)
PREVALENT STATIN USE IN RELATION TO BLOOD CHOLESTEROL TESTING AMONG US ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A POPULATION-BASED COHORT STUDY (2021) (0)
Abstract 18402: Impact of the Use of Different Bleeding Scales on the Rate of 6-Month Bleeding After PCI: Results from the PARIS Registry (2012) (0)
P1389Impact of peripheral arterial disease on provision of discharge pharmacotherapy and longitudinal outcomes in patients with stable angina undergoing percutaneous coronary interventions (2017) (0)
Abstract 16705: Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS (2012) (0)
Abstract 84: Impact of Education on Dual Antiplatelet Therapy Adherence (2012) (0)
SEX-SPECIFIC PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough (2017) (0)
CLINICALLY-BASED PATIENT RISK SCORES AND THE ‘TARGET LESION REVASCULARIZATION PARADOX’ IN PATIENTS WITH MULTI-VESSEL CAD UNDERGOING PCI (2012) (0)
Safety and Efficacy of the Biodegradable-Polymer Everolimus-Eluting Stent vs.Durable-Polymer Drug-Eluting Stents in High-Risk Patients Undergoing PCI: Insights From the TWILIGHT Trial (2020) (0)
Invasive Management in CAD Patients with Stage 4 Renal Dysfunction or on Dialysis (2015) (0)
Abstract 18678: Transcutaneous Aortic Valve Replacement -Is Anticoagulation Protective? (2014) (0)
RESIDUAL INFLAMMATORY RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
TCT-635 Combined and Independent Impact of Diabetes Mellitus and Elevated C-Reactive Protein Levels on Risk for Death and MI Following PCI: Insights From a Large Single-Center Registry (2019) (0)
FREQUENCY AND IMPACT OF SINGLE VERSUS DUAL ANTIPLATELET CESSATION ON ADVERSE CARDIAC EVENTS: RESULTS FROM THE PARIS REGISTRY (2013) (0)
INCIDENCE AND PREDICTORS OF FUNCTIONALLY SIGNIFICANT SIDE BRANCH STENOSES IN CALCIFIED CORONARY LESIONS AFTER ROTATIONAL ATHERECTOMY AND CUTTING BALLOON ANGIOPLASTY: THE RANDOMIZED ORBID-FFR TRIAL (2020) (0)
Left Main PCI With DES Versus CABG: Cautionary Note or Cause for Concern? (2018) (0)
IMPACT OF LEFT VENTRICULAR DYSFUNCTION ON OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AVIATOR REGISTRY (2015) (0)
TCT-330 Risk phenotype and clinical outcomes of patients with stable coronary artery disease treated with PCI stratified by baseline LDL cholesterol. (2016) (0)
Abstract 18932: Safety and Efficacy of New- vs. Early-Generation Drug-Eluting Stents in Elderly Women: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (0)
PHYSICIAN CHOICE OF DISCHARGE ANTITHROMBOTIC REGIMEN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION BASED ON BLEEDING AND ISCHEMIC RISK ASSESSMENT: RESULTS FROM AVIATOR MULTI-CENTER REGISTRY (2014) (0)
TCT-320 Impact of Pre-Procedural High-Sensitivity C-Reactive Protein, LDL-C and SYNTAX Score on Outcomes Following Percutaneous Coronary Intervention (2018) (0)
TCT-225 Impact of Age on the Disruption of Dual Antiplatelet Therapy: Analysis from the PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented) Patients Registry (2015) (0)
TCT-487 Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS Cohort (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Usman Baber?

Usman Baber is affiliated with the following schools:

University of Oklahoma Health Sciences Center
Icahn School of Medicine at Mount Sinai
Columbia University

Usman Baber's Academic­Influence.com Rankings

Usman Baber's Degrees

Why Is Usman Baber Influential?

Usman Baber's Published Works

Published Works

What Schools Are Affiliated With Usman Baber?

Usman Baber's AcademicInfluence.com Rankings